Save Stocks
Viewing
Filtered By
Ordered By
UCB's Kremers Urban Sale Deal Lapses, Divestiture Plan On - Analyst Blog
12/18/2014 3:20:00 PM - Zacks.com


UCB's Kremers Urban Sale Deal Lapses, Divestiture Plan On - Analyst Blog
12/18/2014 3:20:00 AM - Investopedia


UCB Reports Phase III Data on Epilepsy Drug, To File in 2015 - Analyst Blog
12/9/2014 2:50:00 PM - Zacks.com


UCB Presents Primary Study Results From Latest Phase 3 Brivaracetam Study
12/8/2014 1:13:00 AM - RTT News


UCB-Daiichi Sankyo Ink Deal to Sell Vimpat in Japan - Analyst Blog
12/1/2014 3:20:00 PM - Zacks.com


Immunomedics' Veltuzumab Receives Orphan Drug Status - Analyst Blog
11/24/2014 4:20:00 PM - Zacks.com


Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews
11/19/2014 1:00:00 AM - Zacks.com


Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
11/19/2014 1:00:00 AM - Zacks.com


Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
11/18/2014 1:00:00 PM - Investopedia


Will Catalyst Pharmaceuticals' (CPRX) Loss Narrow in Q3? - Analyst Blog
11/12/2014 5:30:00 PM - Zacks.com


UCB to Sell Generics Business, Focus on Core Segments - Analyst Blog
11/10/2014 5:30:00 PM - Zacks.com


UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog
9/17/2014 5:40:00 PM - Zacks.com


Roche's (RHHBY) RoActemra Gets EU Approval for Early RA - Analyst Blog
9/9/2014 4:20:00 PM - Zacks.com


UCB's Epilepsy Drug Vimpat's Label Expanded in the U.S. - Analyst Blog
9/2/2014 3:45:00 PM - Zacks.com


UCB Files Patent Infringement Lawsuit vs. Actavis - Analyst Blog
8/28/2014 3:40:00 PM - Zacks.com


Drug Patent Expirations This Week: UCB, Roche's Genentech
8/8/2014 9:17:00 AM - Seeking Alpha


UCB's Brivaracetam Positive in Phase III Epilepsy Study - Analyst Blog
7/24/2014 4:40:00 PM - Zacks.com


UCB, Dermira Sign Cimzia Dermatology Deal - Analyst Blog
7/7/2014 5:10:00 PM - Zacks.com


UCB's Vimpat Positive for Partial-Onset Seizures - Analyst Blog
6/30/2014 10:50:00 AM - Zacks.com


Sanofi Misses on Q1 Earnings, Lackluster Revs - Analyst Blog
4/30/2014 10:07:01 AM - Zacks.com


UCB Sales Rise in Q1 - Analyst Blog
4/24/2014 3:30:01 PM - Zacks.com


Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog
3/27/2014 10:00:01 AM - Zacks.com


UCB to Return Tozadenant Rights - Analyst Blog
3/26/2014 4:44:01 PM - Zacks.com


Sanofi, UCB Ink Deal - Analyst Blog
3/12/2014 5:10:01 PM - Zacks.com


UCB Misses Earnings Ests, Revs In Line - Analyst Blog
2/27/2014 1:32:01 PM - Zacks.com